Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-048750

Options or other derivatives

  • CTO acquired 2,138,548 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
WACHTER ERIC PHD CTO 2024-12-02 Grant or award · Stock Options (Right to Buy) +2,138,548 2,138,548 D: show line 1 in the form
Loading xslF345X05/ownership.xml…